Drug Patent Expirations in November 2015

Drug Patent Expirations for November 2015

Tradename Applicant Generic Name Patent Number Patent Expiration
PEPCID AC J And J Consumer Inc famotidine 5,667,794*PED Nov 2, 2015
FROVA Endo Pharms frovatriptan succinate 5,464,864 Nov 7, 2015
AXERT Janssen Pharms almotriptan malate 5,565,447*PED Nov 7, 2015
XOPENEX HFA Sunovion levalbuterol tartrate 5,836,299 Nov 17, 2015
VIOXX Merck rofecoxib 5,691,374*PED Nov 18, 2015
SANDOSTATIN Novartis octreotide acetate 5,753,618*PED Nov 19, 2015
PAXIL CR Apotex Technologies paroxetine hydrochloride 6,133,289*PED Nov 19, 2015
PAXIL Apotex Technologies paroxetine hydrochloride 6,080,759*PED Nov 19, 2015
PAXIL CR Apotex Technologies paroxetine hydrochloride 5,872,132*PED Nov 19, 2015
PAXIL Apotex Technologies paroxetine hydrochloride 5,872,132*PED Nov 19, 2015
PAXIL Apotex Technologies paroxetine hydrochloride 6,133,289*PED Nov 19, 2015
PAXIL CR Apotex Technologies paroxetine hydrochloride 5,900,423*PED Nov 19, 2015
PAXIL Apotex Technologies paroxetine hydrochloride 5,900,423*PED Nov 19, 2015
JALYN Glaxosmithkline dutasteride; tamsulosin hydrochloride 5,565,467 Nov 20, 2015
TRACLEER Actelion Pharms Ltd bosentan 5,292,740 Nov 20, 2015
AVODART Glaxosmithkline dutasteride 5,565,467 Nov 20, 2015
ORTHO EVRA Janssen Pharms ethinyl estradiol; norelgestromin 5,876,746 Nov 20, 2015
DITROPAN XL Janssen Pharms oxybutynin chloride 5,840,754*PED Nov 22, 2015
DITROPAN XL Janssen Pharms oxybutynin chloride 5,912,268*PED Nov 22, 2015
DITROPAN XL Janssen Pharms oxybutynin chloride 5,674,895*PED Nov 22, 2015
DITROPAN XL Janssen Pharms oxybutynin chloride 6,262,115*PED Nov 22, 2015
ORBACTIV The Medicines Co oritavancin diphosphate 5,840,684 Nov 24, 2015
CLINOLIPID 20% Baxter Hlthcare olive oil; soybean oil 5,840,757 Nov 24, 2015
THYROGEN Genzyme thyrotropin alfa 5,840,566 Nov 24, 2015
LETAIRIS Gilead ambrisentan 5,840,722 Nov 24, 2015
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.

Contact Us with any questions.
Click here for reuse options!
Copyright 2015 Biotechblog

Comments are closed.

%d bloggers like this: